| Dr Mohamed Nagi Ali, PHARMD | |
|
138 Sudderth Dr, Ruidoso, NM 88345-6025 | |
| (575) 257-1566 | |
| Not Available |
| Full Name | Dr Mohamed Nagi Ali |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 138 Sudderth Dr, Ruidoso, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124435292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP00008115 (New Mexico) | Primary |
| 183500000X | Pharmacist | PHA0019892 (Colorado) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohamed Nagi Ali, PHARMD 138 Sudderth Dr, Ruidoso, NM 88345-6025 Ph: (575) 257-1566 | Dr Mohamed Nagi Ali, PHARMD 138 Sudderth Dr, Ruidoso, NM 88345-6025 Ph: (575) 257-1566 |
News Archive
Women with a family history of breast or ovarian cancer are invited to meet with experts who will advise on preventing or delaying the disease. The University of Leicester's Genetics Education Networking for Innovation and Excellence (GENIE) will hold its third Lifestyle and Cancer Awareness Workshop on Saturday, February 23.
The U.S. Food and Drug Administration is requesting a budget of $4.5 billion to protect and promote the public health as part of the President's fiscal year (FY) 2013 budget – a 17 percent increase over the FDA enacted budget for FY 2012.
Lymphedema is a chronic condition that causes swelling of the limbs and affects physical, mental and social health. It commonly occurs in breast cancer survivors and is the second-most dreaded effect of treatment, after cancer recurrence. Every day, researchers throughout the world learn more about the condition and how it can be treated. Now, University of Missouri researchers are developing a place in cyberspace where relevant and timely information can be easily stored, searched, and reviewed from anywhere with the goal of improving health care through the availability of up-to-date, evidence-based research.
DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the closing of a $36.2 million round of equity financing. The round was led by new investor Split Rock Partners. Funding was also contributed by new investor OrbiMed, and inside investors Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, Highland Capital Management and several private investors.
› Verified 9 days ago
Michael Padilla, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 Sudderth Dr, Ruidoso, NM 88345 Phone: 575-257-8264 | |
Mr. Chris H Woodul, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 138 Sudderth Dr, Ruidoso, NM 88345 Phone: 505-257-1566 Fax: 505-257-4600 | |
Mr. William J Long, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1203 Mechem Dr, Ruidoso, NM 88345 Phone: 575-258-2456 | |
Sarah Goin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 138 Sudderth Dr, Ruidoso, NM 88345 Phone: 575-257-1566 | |
Valerie Hogan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 721 Mechem Dr, Ruidoso, NM 88345 Phone: 575-257-4014 | |
Mrs. Alexis Christianna Meliniotis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1206 Mechem Dr, Ruidoso, NM 88345 Phone: 575-258-2456 Fax: 575-258-2465 |